Vorige

P.J.A. (Pieter-Jan) Haas

Arts-microbioloog

Aandachtsgebieden

  • Bacterial immune evasion
  • Phage display technology
  • Protein expression and engineering
  • Clinical microbiology
  • Infectious diseases
  • Medical mycology

Afdelingen / poliklinieken

Wetenschappelijk onderzoek

Promotiedatum: 5 mei 2006

Titel proefschrift: Staphylococcal drug discovery

Publicaties

Effective Neutrophil Phagocytosis of Aspergillus fumigatus Is Mediated by Classical Pathway Complement Activation Steven G.E. Braem, Suzan H.M. Rooijakkers, Kok P.M. van Kessel, Hans de Cock, Han A.B. Wösten, Jos van Strijp, Pieter-Jan Haas. Journal of Innate Immunity, in press.


Staphylococcus aureus proteins SSL6 and SElX interact with neutrophil receptors as identified using secretome phage display. Fevre C, Bestebroer J, Mebius MM, de Haas CJ, van Strijp JA, Fitzgerald JR, Haas PJ. Cell Microbiol. 2014 May 19.
 

Comparison of the occurrence of mold infection among patients receiving chemotherapy for acute leukemia versus patients undergoing stem cell transplantation. Janssen A, van der Bruggen T, Haas PJ, de Jong PA, Minnema MC. Eur J Haematol. 2011 Jul 6 (IF:2,8).


Directed evolution of chemotaxis inhibitory protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodies. Gustafsson E, Rosén A, Barchan K, van Kessel KP, Haraldsson K, Lindman S, Forsberg C, Ljung L, Bryder K, Walse B, Haas PJ, van Strijp JA, Furebring C.Protein Eng Des Sel. 2010 Feb;23(2):91-101.

Persoonlijke prijzen, subsidies en onderscheidingen

Jun 2010 – Dec 2011: NGI Breakthrough Horizon 93511012: Bacterial Virulence Gene Discovery Using Phage Display Technology